← Back to All Stocks

KVUE - Kenvue Inc.

Health Care
Dividend Aristocrat

Price History

About

Industry

Household & Personal Products

Employees

21,780

Headquarters

United States


Company Overview

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Price

$17.24

52-Week Range

$14 $25

Dividend Yield

4.81%

Dividend Score

C

Dividend

Yield 4.81%
Annual $0.83
Payout 109%
5Y Avg N/A

Valuation

P/E (TTM) 22.7
Fwd P/E 14.2
P/B 3.07
PEG 0.79

Profitability

Profit Margin 9.7%
Op Margin 17.8%
ROE 14.4%
ROA 6.6%

Financial Health

Current Ratio 0.96
Quick Ratio 0.58
Debt/Equity 81%

Cash Flow

Free CF $1.8B
Op CF $2.2B
Total Cash $1.1B

Analyst Consensus

Hold

12 analysts

Target: $20 $18 - $23
+15.0% implied

Dividend Growth

Most Recent Annual Growth

1.98%

3-Year Avg Growth

N/A

5-Year Avg Growth

N/A

Annual Dividends

Year-over-Year Growth

Recent Dividend History

Ex-Dividend Date Amount
Feb 11, 2026 $0.2080
Nov 12, 2025 $0.2080
Aug 13, 2025 $0.2080
May 14, 2025 $0.2050
Feb 12, 2025 $0.2050
Nov 13, 2024 $0.2050
Aug 14, 2024 $0.2050
May 07, 2024 $0.2000
Feb 13, 2024 $0.2000
Nov 07, 2023 $0.2000
Aug 25, 2023 $0.2000

Unlock Full Access

Get unlimited access to all features including our powerful dividend screener, detailed stock analysis, and our dividend growth forecasting tool.

Full Screener

300+ proven dividend growth stocks

Growth Forecasts

Project returns with reinvestment

Deep Analysis

Fundamentals & metrics that matter